Imcyse
Imcyse is a biotech company in LIEGE, Belgium, founded in 2011.
- Headquarters
- LIEGE
- Employees
- 11–50
- Founded
- 2011
- Business Model
- B2B
- Website
- imcyse.com
About
Imcyse develops antigen-specific immunotherapies for severe autoimmune diseases. Its synthetic peptides stimulate immune cells to control inflammatory processes and autoimmune attacks. The approach aims to eliminate cells driving abnormal immune responses while allowing the rest of the immune system to continue functioning normally.
Summary
It lists 11–50 employees.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/imcyse"><img src="https://indexed.vc/api/badge/company/imcyse" alt="Imcyse on Indexed.vc" width="260" height="76" /></a>
